Nanoscale artificial antigen presenting cells for T cell immunotherapy - Wikidata - wikimedia - TriplyDB

Nanoscale artificial antigen presenting cells for T cell immunotherapy

Nanoscale artificial antigen presenting cells for T cell immunotherapy

http://www.wikidata.org/entity/Q33968408

about

Improving the clinical impact of biomaterials in cancer immunotherapy.Biomimetic and synthetic interfaces to tune immune responses Linking form to function: Biophysical aspects of artificial antigen presenting cell design The era of bioengineering: how will this affect the next generation of cancer immunotherapy?Biomaterials for nanoparticle vaccine delivery systems.Towards efficient cancer immunotherapy: advances in developing artificial antigen-presenting cells.CD47 Enhances In Vivo Functionality of Artificial Antigen-Presenting Cells Shaping the future of nanomedicine: anisotropy in polymeric nanoparticle design Killer artificial antigen presenting cells (KaAPC) for efficient in vitro depletion of human antigen-specific T cells.Enrichment and Expansion with Nanoscale Artificial Antigen Presenting Cells for Adoptive Immunotherapy.Antigen-specific T cell Redirectors: a nanoparticle based approach for redirecting T cells.Magnetic field-induced T cell receptor clustering by nanoparticles enhances T cell activation and stimulates antitumor activity.Topology, dynamics, and heterogeneity in immune signaling.Biomimetic particles as therapeutics.Cell membrane-derived nanomaterials for biomedical applications.Surface engineering for lymphocyte programming.The Basics of Artificial Antigen Presenting Cells in T Cell-Based Cancer Immunotherapies Biodegradable nanoellipsoidal artificial antigen presenting cells for antigen specific T-cell activation Immunoengineering with biomaterials for enhanced cancer immunotherapy.Modulating the immune system through nanotechnology.Janus Nanoparticles for T Cell Activation: Clustering Ligands to Enhance Stimulation.Nanoscale artificial antigen presenting cells for cancer immunotherapy.The right touch: design of artificial antigen-presenting cells to stimulate the immune system

P2860

Q26766267-CF487C28-936B-433A-97D5-F72BCEC57BEA Q26801229-ABF3D319-217B-42B6-BD1F-436466426439 Q27002652-9780B3DF-1F95-4593-99EC-3C6F19185317 Q33815087-4366D04B-E28E-439F-96A6-6F599926E1DD Q34345012-815A9DE8-0754-4DC4-9775-E16F2B65E182 Q34428078-7224DDA8-1299-4C97-A770-0E640DBDD8AB Q35563107-5A5BB96C-B685-4291-9029-0EFB1512EB49 Q36279715-394FE5A5-38FF-4D66-8F67-05D2BA377133 Q36454872-C8990959-5DF7-414A-9054-E39A89B97176 Q37370230-CCFCDB6E-E267-4641-8213-D72F4CA88703 Q37708824-99086776-2BFB-4334-BF97-B41243B6D67A Q37731672-4660C7D3-9E31-46E3-84CC-43E5A130CE95 Q38503829-856FE8AF-7C31-4B7F-B0D8-19D045B961DC Q38567436-F8E4ED6C-5484-45B0-8F97-103A1CADEC31 Q39178313-ABAB27C6-9E1A-4716-B01F-D40E2C83964E Q40214162-AE878707-5513-4245-9BE7-CB215C999970 Q41442041-F377D532-6015-46F7-8922-490245D45BF7 Q41495742-519AA8E3-32DF-41EF-9504-366136206C4C Q47732542-329A3EF4-7199-49A4-907A-C677A6CE62FC Q48630939-A20CE556-BB7A-45D0-9F39-0AFAFB1ECC96 Q48644573-E7656DD2-E448-4937-89F2-C56D55587527 Q52662884-00451C87-3079-4A5C-AE5A-92AB76A78B9A Q58619853-34FCEC58-0AA5-47F9-A8C7-82FC25845CE3

P2860

Nanoscale artificial antigen presenting cells for T cell immunotherapy

http://www.wikidata.org/entity/Q33968408

description

2013 nî lūn-bûn

@nan

2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

name

Nanoscale artificial antigen presenting cells for T cell immunotherapy

@ast

Nanoscale artificial antigen presenting cells for T cell immunotherapy

@en

type

label

Nanoscale artificial antigen presenting cells for T cell immunotherapy

@ast

Nanoscale artificial antigen presenting cells for T cell immunotherapy

@en

prefLabel

Nanoscale artificial antigen presenting cells for T cell immunotherapy

@ast

Nanoscale artificial antigen presenting cells for T cell immunotherapy

@en

P1433

Q33968408-9CE60232-A912-4CC3-BE65-7AD6BADFEA5B

P1476

Q33968408-6BF0F4A6-210A-4927-B30B-5CC3426D8BCA

P2093

Q33968408-011BED66-0CDE-47E2-8BB9-83A9476C10DE

Q33968408-06FE5832-16D3-414B-9144-859365A3ECAE

Q33968408-0EBD97DA-0A82-4B8D-BF7E-CCADA0206DEE

Q33968408-2A7DB3D6-551E-461C-BBEB-24A44BD7FB5B

Q33968408-37DC666D-3870-4679-A186-221937D6DD9E

Q33968408-577D0E7F-348C-4169-9AE3-8CA0CDA59F3E

Q33968408-69F14649-77D1-423F-B38C-F0C8FB3CBEC6

Q33968408-6CD3B209-BE4A-4224-BFF3-2BC2BBC10DA1

Q33968408-6FAA7EED-92E9-4B0D-BD72-26CC585AC52D

Q33968408-DEB5BE4D-DA38-410E-8F0E-0E9D971408E4

P2860

Q33968408-0070F843-1377-428D-A16F-AFEEB6A27216

Q33968408-057736DE-D07C-4794-BE11-77E9B3204BDF

Q33968408-0D40DF10-13B5-41B3-B7C3-C3CFD304714A

Q33968408-0F62356A-6DF1-4414-AB74-962024466FBB

Q33968408-121BA054-7373-474D-AA98-998105229C65

Q33968408-121FBEA8-8169-445B-8E3D-0DBEDDFBB4E8

Q33968408-1862A07B-70C1-4A5C-A201-8DCA0E3D0DCC

Q33968408-23F44B86-8334-47A7-9191-CD91AF6D80E4

Q33968408-29555D3A-6F7D-4100-8D44-A5724FAEB70F

Q33968408-2A340117-D859-441D-87F0-A0CCDFE76FF5

P304

Q33968408-B3F3A431-1D39-47D7-AADE-91A3A50B7150

P31

Q33968408-B1C36FE3-C6B6-488F-8EFF-5A95E1F37CE0

P356

Q33968408-4530BB06-B646-4B74-AC16-1A0FB33A0A51

P433

Q33968408-B7A94E8E-34C9-4E59-86E4-EBCF88643403

P478

Q33968408-520EF933-B476-41B0-ACC8-C4245EA67018

P50

Q33968408-01EE1ACC-14F4-4AC7-B51A-167A9C6F8A21

Q33968408-50DFC1CC-D61A-4834-9F48-CCE95F9E8058

P577

Q33968408-2F7CB83D-78EE-48DF-A969-3A2B212376E6

P698

Q33968408-8A03D989-F550-40E8-8582-A70637423074

P921

Q33968408-E4E56D09-3A8A-43C3-B0DD-EEC23386967B

P932

Q33968408-97BBC638-C024-4CD7-B492-921538DB315F

P356

J.NANO.2013.06.015

P1433

Nanomedicine: Nanotechnology, Biology and Medicine

P1476

Nanoscale artificial antigen presenting cells for T cell immunotherapy

@en

P2093

Andrés De León Medero

http://www.w3.org/2001/XMLSchema#string

Anne Richter

http://www.w3.org/2001/XMLSchema#string

Joan Glick Bieler

http://www.w3.org/2001/XMLSchema#string

Jonathan Schneck

http://www.w3.org/2001/XMLSchema#string

Leah Sibener

http://www.w3.org/2001/XMLSchema#string

Malarvizhi Durai

http://www.w3.org/2001/XMLSchema#string

Mario Assenmacher

http://www.w3.org/2001/XMLSchema#string

Mathias Oelke

http://www.w3.org/2001/XMLSchema#string

Michael Edidin

http://www.w3.org/2001/XMLSchema#string

Michaela Niemöller

http://www.w3.org/2001/XMLSchema#string

P2860

Understanding biophysicochemical interactions at the nano-bio interface

T cell activation

Immunological properties of engineered nanomaterials

T cell receptor-proximal signals are sustained in peripheral microclusters and terminated in the central supramolecular activation cluster.

Immunosuppressive strategies that are mediated by tumor cells

Antigen density presented by dendritic cells in vivo differentially affects the number and avidity of primary, memory, and recall CD8+ T cells.

Increased TCR avidity after T cell activation: a mechanism for sensing low-density antigen.

T cell receptor binding kinetics required for T cell activation depend on the density of cognate ligand on the antigen-presenting cell.

Memories that last forever: strategies for optimizing vaccine T-cell memory.

Soluble peptide-MHC monomers cause activation of CD8+ T cells through transfer of the peptide to T cell MHC molecules.

P304

119-129

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.NANO.2013.06.015

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-07-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23891987

http://www.w3.org/2001/XMLSchema#string

P921

P932

4114774

http://www.w3.org/2001/XMLSchema#string